These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 25815749)

  • 1. Accidental poisoning with 6-MP in a sibling of pediatric patient treated with maintenance chemotherapy.
    Fernandez A; Gervoise-Boyer MJ; Chambost H; Coze C; Andre N
    J Pediatr Hematol Oncol; 2015 May; 37(4):331-2. PubMed ID: 25815749
    [No Abstract]   [Full Text] [Related]  

  • 2. The presentation of 6-mercaptopurine overdose in ED.
    Gupta N; Lee CC; Lim TH; Singer AJ
    Am J Emerg Med; 2009 May; 27(4):513.e1-2. PubMed ID: 19555631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic ingestion of 6-mercaptopurine by young siblings of pediatric oncology patients.
    Chow LM; Capra M; Levichek Z; Koren G; Grant RM
    J Pediatr; 2004 May; 144(5):669-71. PubMed ID: 15127011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
    Melachuri S; Gandrud L; Bostrom B
    Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thiopurine S-methyltransferase (TPMT) polymorphisms in children with acute lymphoblastic leukemia, and the need for reduction or cessation of 6-mercaptopurine doses during maintenance therapy: the Polish multicenter analysis.
    Peregud-Pogorzelski J; Tetera-Rudnicka E; Kurzawski M; Brodkiewicz A; Adrianowska N; Mlynarski W; Januszkiewicz D; Drozdzik M
    Pediatr Blood Cancer; 2011 Oct; 57(4):578-82. PubMed ID: 21319286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic and pharmacogenetic analysis of 6-mercaptopurine in paediatric patients with acute lymphoblastic leukaemia.
    Hawwa AF; Collier PS; Millership JS; McCarthy A; Dempsey S; Cairns C; McElnay JC
    Br J Clin Pharmacol; 2008 Dec; 66(6):826-37. PubMed ID: 18823306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe hypoglycemic seizures in a child receiving 6-mercaptopurine.
    El-Bitar MK; Muwakkit SA; Dabbagh O
    J Pediatr Hematol Oncol; 2011 Mar; 33(2):e75-6. PubMed ID: 21343747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiopurine methyltransferase polymorphisms and mercaptopurine tolerance in Turkish children with acute lymphoblastic leukemia.
    Albayrak M; Konyssova U; Kaya Z; Gursel T; Guntekin S; Percin EF; Kocak U
    Cancer Chemother Pharmacol; 2011 Nov; 68(5):1155-9. PubMed ID: 21400026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
    Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
    Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral methotrexate/6-mercaptopurine may be superior to a multidrug LSA2L2 Maintenance therapy for higher risk childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.
    Schmiegelow K; Heyman M; Kristinsson J; Mogensen UB; Rosthøj S; Vettenranta K; Wesenberg F; Saarinen-Pihkala U;
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):385-92. PubMed ID: 19648786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of obesity in paediatric leukaemia treatment: it is not just size that matters.
    Tolbert J; Kearns GL
    Arch Dis Child; 2015 Jan; 100(1):101-5. PubMed ID: 25336436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal hypertension develops in a subset of children with standard risk acute lymphoblastic leukemia treated with oral 6-thioguanine during maintenance therapy.
    Broxson EH; Dole M; Wong R; Laya BF; Stork L
    Pediatr Blood Cancer; 2005 Mar; 44(3):226-31. PubMed ID: 15503293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism of 6-mercaptopurine in the erythrocytes, liver, and kidney of rats during multiple-dose regimens.
    Innocenti F; Danesi R; Bocci G; Fogli S; Di Paolo A; Del Tacca M
    Cancer Chemother Pharmacol; 1999; 43(2):133-40. PubMed ID: 9923818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 15. The impact of high-dose methotrexate on intracellular 6-mercaptopurine disposition during interval therapy of childhood acute lymphoblastic leukemia.
    Adam de Beaumais T; Dervieux T; Fakhoury M; Medard Y; Azougagh S; Zhang D; Yakouben K; Jacqz-Aigrain E
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):653-8. PubMed ID: 20033410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of ITPA 94C>A and risk of adverse effects among patients with acute lymphoblastic leukaemia treated with 6-mercaptopurine.
    Wan Rosalina WR; Teh LK; Mohamad N; Nasir A; Yusoff R; Baba AA; Salleh MZ
    J Clin Pharm Ther; 2012 Apr; 37(2):237-41. PubMed ID: 21545474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics and factors affecting growth in long-term survivors of cancer.
    Talvensaari KK; Knip M; Lanning P; Lanning M
    Med Pediatr Oncol; 1996 Mar; 26(3):166-72. PubMed ID: 8544798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear winter.
    Lesesve JF; Mansuy L
    Transfusion; 2005 Sep; 45(9):1403. PubMed ID: 16131370
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy plays a major role in the inhibition of catch-up growth during maintenance therapy for childhood acute lymphoblastic leukemia.
    Groot-Loonen JJ; Otten BJ; van t' Hof MA; Lippens RJ; Stoelinga GB
    Pediatrics; 1995 Oct; 96(4 Pt 1):693-5. PubMed ID: 7567332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of red blood cell thiopurine metabolites in children with acute lymphoblastic leukemia who received oral mercaptopurine twice daily or once daily: a Pediatric Oncology Group study (now The Children's Oncology Group).
    Bell BA; Brockway GN; Shuster JJ; Erdmann G; Sterikoff S; Bostrom B; Camitta BM;
    Pediatr Blood Cancer; 2004 Aug; 43(2):105-9. PubMed ID: 15236274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.